The investigators will perform a pilot 4-week at home study with 48 individuals with stroke and 10 therapists working with stroke patients to examine the feasibility and effect of a wearable focal muscle vibration device on upper limb strength and function.
Stroke often leads to significant impairment of upper limb function and is associated with decreased quality of life. Patients have difficulty moving out of the upper extremity flexion synergies that often dominate attempts to function after stroke. Change in muscle activation is the key underlying factor. Despite study results from several interventions for muscle activation and motor coordination, wide-scale adoption remains largely elusive due to the lack of sustainability of those interventions. The main reasons for the unsustainability are under-doses of the interventions and low patient compliance and participation. Recent studies among individuals without disabilities as well as those with strokes have shown that with focal vibration, there is greater potential to increase and coordinate muscle recruitment and build muscle strength and endurance. This form of treatment could widely benefit stroke patients and therapists who are in need of sustainable intervention that is effective and efficient to building muscle work capacity for function. Thus, the aims of this study are to evaluate the usability and feasibility of a novel vibration-based wearable device for upper limb rehabilitation in stroke patients. Forty-eight stroke patients and 10 therapists working with those stroke patients will be recruited to evaluate the usability of the device. All stroke patients will participate in a 4-week in-home vibration treatment to evaluate the feasibility of the device. Patients will be randomized into four groups receiving vibrations with different frequency (60 Hz or 120 Hz) and amplitude (0.2mm or 2mm). All groups will follow a prescribed dose of vibration based on the therapists' recommendations. Strength and functional outcomes will be measured before and after the 4-week in-home intervention. The investigators hypothesize that all groups will show an increase in grip strength and upper limb function at the end of study compared to baseline and that the increases in outcomes will be different in different groups. The investigators also expect all participants will tolerate the wearable device without adverse side effects and report high levels of satisfaction with the device. This pilot study may help to develop a novel sustainable wearable system providing vibration-based muscle activation for upper limb function rehabilitation. It may provide patients opportunity to apply the prescribed vibratory stimuli in-home and/or at community settings. It may also allow therapists to monitor treatment usage and patient performance and to adjust the treatment doses based on progression.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
4
WearUL is a patent pending wearable rehabilitation technology that targets localized vibration massage therapy directly onto the body. The frequency and amplitude combinations to be delivered by WearUL are safe and effective in clinical and research settings based on previous studies on focal vibration.
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Usability of the WearUL as assessed by the System Usability Scale (SUS)
SUS is a reliable tool for measuring the usability of a device or system
Time frame: 4 weeks
Usability of the WearUL app as assessed by the mHealth App Usability Questionnaire (MAUQ)
MAUQ is a reliable and valid questionnaire to assess mHealth app usability
Time frame: 4 weeks
Changes in grip strength
the affected side grip strength measured by a dynamometer
Time frame: Change from Baseline Grip Strength at 4 weeks
Changes in arm and hand function as assessed by CAHAI-7
Chedoke Arm and Hand Activity Inventory - 7
Time frame: Change from Baseline CAHAI-7 at 4 weeks
Changes in sensorimotor impairment as assessed by FMA-UE
Fugl-Meyer Assessment of the Upper Extremity
Time frame: Change from Baseline FMA-UE at 4 weeks
Changes in upper extremity performance as assessed by ARAT
Action Research Arm Test
Time frame: Change from Baseline ARAT at 4 weeks
Changes in self-reported functional upper extremity performance as assessed by MAL
Motor Activity Log
Time frame: Change from Baseline MAL at 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.